Metozolv ODT Drug Patent Profile
✉ Email this page to a colleague
When do Metozolv Odt patents expire, and when can generic versions of Metozolv Odt launch?
Metozolv Odt is a drug marketed by Salix Pharms and is included in one NDA.
The generic ingredient in METOZOLV ODT is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metozolv Odt
A generic version of Metozolv ODT was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
Summary for Metozolv ODT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Patent Applications: | 1,579 |
Formulation / Manufacturing: | see details |
DailyMed Link: | Metozolv ODT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for Metozolv ODT
Paragraph IV (Patent) Challenges for METOZOLV ODT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
METOZOLV ODT | Orally Disintegrating Tablets | metoclopramide hydrochloride | 5 mg and 10 mg | 022246 | 1 | 2010-08-24 |
US Patents and Regulatory Information for Metozolv ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-001 | Sep 4, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-002 | Sep 4, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Metozolv ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-001 | Sep 4, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Salix Pharms | METOZOLV ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246-002 | Sep 4, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Metozolv ODT
See the table below for patents covering Metozolv ODT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 4943581 | ⤷ Try a Trial | |
Japan | 2001509478 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 9902140 | ⤷ Try a Trial | |
Australia | 8399298 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |